July 15, 2025 · Form 4 insider transaction
Upadhyay Suketu bought 75.904 shares of Vertex Pharmaceuticals Incorporated at $469.34 per share, a transaction worth $35.6K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.